Luciana Ribeiro Garzoni

Luciana Ribeiro Garzoni


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in Experimental Cell Research
Verified
Journal Article
Closed access
LGLuciana Ribeiro Garzoni
Luciana Ribeiro Garzoni
MRMaria Isabel D. Rossi
Maria Isabel D. Rossi
ABAna P.D.N. de Barros
Ana P.D.N. de Barros
VGVirgínia Guarani
Virgínia Guarani
MKMichelle Keramidas
Michelle Keramidas
RBRadovan Borojevic
Radovan Borojevic

15 March 2008 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
LGLuciana Ribeiro Garzoni
Luciana Ribeiro Garzoni
DADaniel Adesse
Daniel Adesse
MSMaurilio José Soares
Maurilio José Soares
MRMaria Isabel Doria Rossi
Maria Isabel Doria Rossi
RBRadovan Borojevic
Radovan Borojevic
MMMaria de Nazareth Leal de Meirelles
Maria de Nazareth Leal de Meirelles
Cardiac damages caused by in vivo infection with Trypanosoma cruzi are still not fully clarified. Here we describe for the first time an in vitro mod

1 January 2011 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
DADaniel Adesse
Daniel Adesse
EAEduardo Meirelles Azzam
Eduardo Meirelles Azzam
MMMaria de Nazareth L. Meirelles
Maria de Nazareth L. Meirelles
JUJulio A. Urbina
Julio A. Urbina
LGLuciana Ribeiro Garzoni
Luciana Ribeiro Garzoni
We present the results of the first detailed study of the antiproliferative and ultrastructural effects of amiodarone on Trypanosoma cruzi , the causative agent of Chagas' disease. Moreover, we report the effects of this compound on the recovery of F-actin fibrils, connexin43, and contractility in T. cruzi -infected cardiac myocytes. Amiodarone is the most prescribed class III antiarrhythmic agent and is frequently used for the symptomatic treatment of Chagas' disease patients with cardiac compromise. In addition, recent studies identified its antifungal and antiprotozoal activities, which take place through Ca 2+ homeostasis disruption and ergosterol biosynthesis blockade. We tested different concentrations of amiodarone (2.5 to 10 μM) on infected primary cultures of heart muscle cells and observed a dose- and time-dependent effect on growth of the clinically relevant intracellular amastigote form of T. cruzi . Ultrastructural analyses revealed that amiodarone had a profound effect on intracellular amastigotes, including mitochondrial swelling and disorganization of reservosomes and the kinetoplast and a blockade of amastigote-trypomastigote differentiation. Amiodarone showed no toxic effects on host cells, which recovered their F-actin fibrillar organization, connexin43 distribution, and spontaneous contractility concomitant with the drug-induced eradication of the intracellular parasites. Amiodarone is, therefore, a promising compound for the development of new drugs against T. cruzi .

1 January 2012 in Frontiers in Immunology
Verified
Journal Article
Open access
CCClaudia Magalhaes Calvet
Claudia Magalhaes Calvet
TMTatiana G. Melo
Tatiana G. Melo
LGLuciana Ribeiro Garzoni
Luciana Ribeiro Garzoni
FJFrancisco O. R. Oliveira Jr.
Francisco O. R. Oliveira Jr.
DNDayse T. Silva Neto
Dayse T. Silva Neto
MPMirian Claudia Pereira
Mirian Claudia Pereira
Trypanosoma cruzi, the etiological agent of Chagas disease, exhibits multiple strategies to ensure its establishment and persistence in the host. Although this parasite has the ability to infect different organs, heart impairment is the most frequent clinical manifestation of the disease. Advances in knowledge of T. cruzi–cardiomyocyte interactions have contributed to a better understanding of the biological events involved in the pathogenesis of Chagas disease. This brief review focuses on the current understanding of molecules involved in T. cruzi–cardiomyocyte recognition, the mechanism of invasion, and on the effect of intracellular development of T. cruzi on the structural organization and molecular response of the target cell.

10 July 2014 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
LNLindice Mitie Nisimura
Lindice Mitie Nisimura
VEVanessa Estato
Vanessa Estato
ESElen Mello de Souza
Elen Mello de Souza
PRPatricia A. Reis
Patricia A. Reis
MLMarcos Adriano Lessa
Marcos Adriano Lessa
LGLuciana Ribeiro Garzoni
Luciana Ribeiro Garzoni
Cardiomyopathy is the main clinical form of Chagas disease (CD); however, cerebral manifestations, such as meningoencephalitis, ischemic stroke and cognitive impairment, can also occur. The aim of the present study was to investigate functional microvascular alterations and oxidative stress in the brain of mice in acute CD. Acute CD was induced in Swiss Webster mice (SWM) with the Y strain of Trypanosoma cruzi (T. cruzi). Cerebral functional capillary density (the number of spontaneously perfused capillaries), leukocyte rolling and adhesion and the microvascular endothelial-dependent response were analyzed over a period of fifteen days using intravital video-microscopy. We also evaluated cerebral oxidative stress with the thiobarbituric acid reactive species TBARS method. Compared with the non-infected group, acute CD significantly induced cerebral functional microvascular alterations, including (i) functional capillary rarefaction, (ii) increased leukocyte rolling and adhesion, (iii) the formation of microvascular platelet-leukocyte aggregates, and (iv) alteration of the endothelial response to acetylcholine. Moreover, cerebral oxidative stress increased in infected animals. We concluded that acute CD in mice induced cerebral microvasculopathy, characterized by a reduced incidence of perfused capillaries, a high number of microvascular platelet-leukocyte aggregates, a marked increase in leukocyte-endothelium interactions and brain arteriolar endothelial dysfunction associated with oxidative stress. These results suggest the involvement of cerebral microcirculation alterations in the neurological manifestations of CD. Chagas disease (CD) is a neglected tropical illness caused by the parasite Trypanosoma cruzi (T. cruzi). It is endemic in Latin America and affects 10 million people worldwide. Meningoencephalitis occurs in children with acute CD and in immunosuppressed patients suffering acute CD reactivation. During the chronic phase, cerebral manifestations, including ischemic stroke and cognitive impairment, can also occur. Although microvascular alterations have been implicated in Chagas cardiomyopathy, the main clinical form of the disease, there is a lack of discussion in some studies regarding alterations of the cerebral microcirculation in CD. In the present study, we evaluated the functionality of the cerebral microcirculation in mice infected by T. cruzi. Utilizing an intravital video-microscope, we observed in the brain of infected mice a reduction in the number of perfused capillaries, an increased interaction between inflammatory cells and venules, the presence of microvascular platelet-leukocyte aggregates and alterations in the dilatation capacity of arterioles. Moreover, cerebral oxidative stress was increased in infected animals. We concluded that acute CD induced cerebral microvasculopathy.

1 January 2018 in Experimental Cell Research
Verified
Journal Article
Open access
PFPatrícia M. Ferrão
Patrícia M. Ferrão
LNLíndice M. Nisimura
Líndice M. Nisimura
FCFundação C. Cruz
Fundação C. Cruz
Marcelo Gerardin Poirot LandMarcelo Gerardin Poirot Land
Marcelo Gerardin Poirot Land
MPMirian Claudia Pereira
Mirian Claudia Pereira
LGLuciana Ribeiro Garzoni
Luciana Ribeiro Garzoni
Chagasic cardiomyopathy (CC) is the main manifestation of Chagas Disease (CD). CC is a progressive dysfunctional illness, in which transforming growth factor beta (TGF-β) plays a central role in fibrogenesis and hypertrophy. In the present study, we tested in a three-dimensional (3D) model of cardiac cells culture (named cardiac spheroids), capable of mimicking the aspects of fibrosis and hypertrophy observed in CC, the role of TGF-β pathway inhibition in restoring extracellular matrix (ECM) balance disrupted by T. cruzi infection. Treatment of T. cruzi-infected cardiac spheroids with SB 431542, a selective inhibitor of TGF-β type I receptor, resulted in a reduction in the size of spheroids, which was accompanied by a decrease in parasite load and in fibronectin expression. The inhibition of TGF-β pathway also promoted an increase in the activity of matrix metalloproteinase (MMP)-2 and a decrease in tissue inhibitor of matrix metalloproteinase (TIMP)-1 expression, which may be one of the mechanisms regulating extracellular matrix remodeling. Therefore, our study provides new insights into the molecular mechanisms by which inhibition of TGF-β signaling reverts fibrosis and hypertrophy generated by T. cruzi during CC and also highlights the use of cardiac spheroids as a valuable tool for the study of fibrogenesis and anti-fibrotic compounds.